Research and specialist diagnostic molecular services
We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.
Research and specialist diagnostic molecular services
We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.
“In situ” hybridization (FISH)
Highly sensitive technique that allows us to detect chromosomal alterations (number of copies of a gene or a chromosomal rearrangements) in different neoplasms for diagnosis and/or targeted treatment, using probes labeled with a fluorochrome.
Molecular Biology
Molecular biology tools allow us to specifically detect and quantify the genetic material in a biological sample, having a great impact on both the diagnosis of cancer and hereditary and infectious diseases. The appearance of new faster and more precise techniques (arrays or NGS), allow us to perform global genomic analyzes in a short period of time.
News
ENCORAFENIB PLUS CETUXIMAB AS A NEW STANDARD OF
BEACON CRC evaluated encorafenib plus cetuximab with or without binimetinib versus investigators’ choice of
FDA APPROVES PEMBROLIZUMAB FOR ADVANCED OR METASTATIC ESOPHAGEAL/GASTROESOPHAGEAL
The United States Food and Drug Administration (FDA) has granted approval for Merck’s anti-programmed
RISK ASSESSMENT FOR DISTANT METASTASIS IN DIFFERENTIATED THYROID
The authors of this case–control study compared the ThyroSeq genetic profiles of 62 patients
VALIDATION OF A 22-GENE GENOMIC CLASSIFIER IN PATIENTS
In this ancillary analysis of the RTOG 9601 study, the researchers validated a 22-gene
6Q DELETION IN WALDENSTRÖM MACROGLOBULINAEMIA NEGATIVELY AFFECTS TIME
Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic
